Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011-2021).
Saved in:
| Title: | Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011-2021). |
|---|---|
| Authors: | Aleksi A; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada., Jobin KD; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., Hannouf MB; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada., Husi P; Department of Cellular, Molecular and Microbial Biology, University of Calgary, Calgary, AB T2N 4N1, Canada., Halperin H; Department of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada., White-Gloria C; Department of Biochemistry, University of Calgary, Calgary, AB T2N 4N1, Canada., Abedin T; Department of Statistics, University of Calgary, Calgary, AB T2N 4N1, Canada., Ruether D; Department of Medical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, AB T2N 5G2, Canada. |
| Source: | Current oncology (Toronto, Ont.) [Curr Oncol] 2026 May 14; Vol. 33 (5). Date of Electronic Publication: 2026 May 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
